{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:41:21Z","timestamp":1762623681391},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/mop.0000000000000267","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T17:31:19Z","timestamp":1438709479000},"page":"649-655","source":"Crossref","is-referenced-by-count":8,"title":["New developments in allergen immunotherapy"],"prefix":"10.1097","volume":"27","author":[{"given":"Anusha","family":"Vadlamudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"IS","key":"R1-18-20210206","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599814561600","article-title":"Clinical practice guideline: allergic rhinitis.","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R2-18-20210206","first-page":"1","article-title":"Trends in asthma prevalence, healthcare use, and mortality in the United States, 2001-2010.","volume":"94","author":"Akinbami","year":"2012","journal-title":"NCHS data brief"},{"key":"R3-18-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2010.10.020","article-title":"Costs of asthma in the United States: 2002-2007.","volume":"127","author":"Barnett","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R4-18-20210206","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma, and ImmunologyEuropean Academy of Allergy and Clinical ImmunologyPRACTALL consensus report.","volume":"131","author":"Burks","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R5-18-20210206","first-page":"363","article-title":"Allergy immunotherapy: what is the evidence for cost saving Curr Opin Allergy Clin I","volume":"14","author":"Hankin","year":"2014","journal-title":"mmunol"},{"key":"R6-18-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/MOP.0b013e328361a496","article-title":"An update on venom allergy.","volume":"25","author":"Shaker","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"R7-18-20210206","first-page":"1","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis.","volume":"1","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-18-20210206","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of sublingual immunotherapy with grass pollen immunotherapy.","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-18-20210206","first-page":"85","article-title":"Prevention of new sensitizations by specific immunotherapy in children with rhinitis andor asthma monosensitized to house dust mite.","volume":"17","author":"Inal","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R10-18-20210206","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"R11-18-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989.","volume":"92","author":"Reid","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"R12-18-20210206","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation of near-fatal reactions to allergen immunotherapy injections.","volume":"117","author":"Amin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R13-18-20210206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaip.2014.01.004","article-title":"AAAAIACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.","volume":"2","author":"Epstein","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R14-18-20210206","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen Immunotherapy: a practice parameter third update.","volume":"127","author":"Cox","year":"2011","journal-title":"J All Clin Immunol"},{"key":"R15-18-20210206","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1398-9995.2011.02583.x","article-title":"Systematic reviews of sublingual immunotherapy (SLIT).","volume":"66","author":"Radulovic","year":"2011","journal-title":"Allergy"},{"key":"R16-18-20210206","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2500\/aap.2015.36.3830","article-title":"Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).","volume":"36","author":"Tabatabaian","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"R17-18-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2500\/aap.2014.35.3708","article-title":"Sublingual immunotherapy for aeroallergens: Status in the United States.","volume":"35","author":"Cox","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"R18-18-20210206","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents.","volume":"127","author":"Blaiss","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R19-18-20210206","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R20-18-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R22-18-20210206","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.","volume":"120","author":"Didier","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R23-18-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.","volume":"123","author":"Wahn","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R24-18-20210206","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.","volume":"130","author":"Cox","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R25-18-20210206","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.","volume":"131","author":"Creticos","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R26-18-20210206","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R27-18-20210206","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4168\/aair.2015.7.2.118","article-title":"Three-year follow-up results of sublingual immunotherapy in patients with allergic rhinitis sensitized to house dust mites.","volume":"7","author":"Kim","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"R28-18-20210206","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1398-9995.2009.02194.x","article-title":"Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.","volume":"64","author":"Ott","year":"2009","journal-title":"Allergy"},{"key":"R29-18-20210206","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cea.12100","article-title":"Posttreatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.","volume":"43","author":"Didier","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"R30-18-20210206","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1586\/1744666X.2014.957677","article-title":"Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass pollen induced allergic rhinoconjunctivitis: 5 years of experience.","volume":"10","author":"Didier","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R31-18-20210206","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.","volume":"133","author":"Bergmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R32-18-20210206","first-page":"1292","article-title":"Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis J Allergy Clin I","volume":"118","author":"Bussmann","year":"2006","journal-title":"mmunol"},{"key":"R33-18-20210206","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1398-9995.2006.00974.x","article-title":"Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multicentre, randomized, dose-response study.","volume":"61","author":"Werfel","year":"2006","journal-title":"Allergy"},{"key":"R34-18-20210206","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2013.02.044","article-title":"Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systemic review and meta-analysis of randomized controlled trials.","volume":"132","author":"Bae","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R35-18-20210206","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2007.04.008","article-title":"Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.","volume":"120","author":"Panjo","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R37-18-20210206","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R38-18-20210206","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy.","volume":"135","author":"Narisety","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R39-18-20210206","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaci.2014.12.1917","article-title":"Sublingual immunotherapy for peanut allergy: long term follow-up of a randomized multicenter trial.","volume":"135","author":"Burks","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R40-18-20210206","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial.","volume":"135","author":"Tang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R41-18-20210206","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy.","volume":"372","author":"DuToit","year":"2015","journal-title":"NEJM"},{"key":"R42-18-20210206","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMe1500186","article-title":"Preventing peanut allergy through early consumption: ready for prime time","volume":"372","author":"Gruchalla","year":"2015","journal-title":"NEJM"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:30:04Z","timestamp":1620963004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201510000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000267","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}